Wegovy HD’s approval came on the cusp of the drug’s patent expiry in India and China, which leaves it open to some biosimilar ...

Novartis has signed an agreement to acquire SNV4818, a pan-mutant selective Phosphoinositide 3-kinase alpha (PI3Kα) inhibitor ...

An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...

The streamlined framework is part of the UK Government’s plans to ensure the life sciences sector reaches its full potential.

Congruence Therapeutics has completed a $39.5m financing round to advance its portfolio of small molecule correctors into the clinic.

The FDA has issued a CRL to Aldeyra Therapeutics for its new drug application (NDA) of reproxalap to treat dry eye disease.

R1 Therapeutics has raised $77.5m in an oversubscribed Series A funding to advance AP306 for hyperphosphatemia in CKD ...

GSK's RSV jab, Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA across the high-risk ...

The court ruling reverses several changes by the CDC’s vaccine panel to childhood immunisation recommendations.

While the FDA can legally make prescription drugs OTC, legal expert Heidi Gertner notes that this wider shift depends on ...

In a recent article, Sanofi presented preclinical data for an in vivo CAR-T platform that reengineers T cells directly within the body.

Quintessence's technology is designed to simplify the bio-separation process in CGT manufacturing while reducing production costs.